BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3011153)

  • 1. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
    Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
    Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Essex M
    Ann Intern Med; 1985 May; 102(5):623-6. PubMed ID: 2984972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
    Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
    McFadden T; Jason JM; Feorino P
    JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
    Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
    Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
    Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
    AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.
    Madhok R; Melbye M; Lowe GD; Forbes CD; Froebel KS; Bodner AJ; Biggar RJ
    Lancet; 1985 Mar; 1(8427):524-5. PubMed ID: 2857891
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of specific antibodies for HTLV in French blood donors].
    Schaffar-Deshayes L; Couroucé AM; Monplaisir N; Chavance M; Lévy JP
    Rev Fr Transfus Immunohematol; 1984 Sep; 27(4):509-11. PubMed ID: 6095411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and early natural history of HTLV-III antibodies in persons with hemophilia.
    Eyster ME; Goedert JJ; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA
    JAMA; 1985 Apr; 253(15):2219-23. PubMed ID: 2983132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state].
    Aymard JP; Janot C; Chermann JC; Briquel ME; Perrier P; Alexandre P; Streiff F
    Rev Fr Transfus Immunohematol; 1985 Jun; 28(3):261-5. PubMed ID: 2994201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain.
    Kitchen L; Leal M; Wichmann I; Lissen E; Ollero M; Allan JS; McLane MF; Essex M
    Blood; 1985 Dec; 66(6):1473-5. PubMed ID: 2998515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
    Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
    AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
    Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
    Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.